Make your own free website on Tripod.com

Clinically Isolated Syndromes Abstracts - 01

  1. Cortical Atrophy is relevant in Multiple Sclerosis at clinical onset
    J Neurol 2007 Sep;254(9):1212-20

  2. MRI criteria for Multiple Sclerosis in patients presenting with Clinically Isolated Syndromes: a multicenter retrospective study
    Lancet Neurol 2007 Aug;6(8):677-86

  3. Clinically Isolated Syndromes suggestive of Multiple Sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
    Lancet Neurol 2005 May;4(5):281-8

  4. Is Optic Neuritis more benign than other first attacks in Multiple Sclerosis
    Ann Neurol 2005 Feb;57(2):210-5

  5. Bulk Abstracts - Newer
    Clinically Isolated Syndromes Abstracts #2

  6. Elevated White Matter Myo-Inositol in Clinically Isolated Syndromes suggestive of Multiple Sclerosis
    Brain 2004 Jun;127(Pt 6):1361-9

  7. Simple and complex movement-associated functional MRI changes in patients at presentation with Clinically Isolated Syndromes suggestive of Multiple Sclerosis
    Hum Brain Mapp 2004 Feb;21(2):108-17

  8. The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
    Neurology 2003 Sep 9;61(5):602-11

  9. Longitudinal evaluation of Depression and Anxiety in patients with Clinically Isolated Syndrome at high risk of developing early Multiple Sclerosis
    Mult Scler 2003 Jun;9(3):302-6

  10. New Diagnostic Criteria for Multiple Sclerosis: Application in first DeMyelinating episode
    Neurology 2003 Jan 14;60(1):27-30

  11. Quantitative 1H MRS imaging 14 years after presenting with a Clinically Isolated Syndrome suggestive of Multiple Sclerosis
    Mult Scler 2002 May;8(3):207-10

  12. A longitudinal study of abnormalities on MRI and disability from Multiple Sclerosis
    N Engl J Med. 2002 Jan 17;346(3):199-200

  13. Effect of early Interferon treatment on conversion to Definite Multiple Sclerosis: a randomized study
    Lancet 2001 May 19;357(9268):1576-82

  14. Magnetization Transfer Imaging in Clinically Isolated Syndromes suggestive of Multiple Sclerosis
    AJNR Am J NeuroRadiol 2001 May;22(5):947-51

  15. Effect of early Interferon treatment on conversion to definite Multiple Sclerosis: a randomized study
    Lancet 2001 May 19;357(9268):1576-1582

  16. Measurement of Spinal Cord area in Clinically Isolated Syndromes suggestive of Multiple Sclerosis
    J Neurol NeuroSurg Psychiatry 2001 Apr;70(4):544-7

  17. Conversion to Clinically Definite Multiple Sclerosis after Isolated Spinal Cord Syndrome: Value of Brain and Spinal MRI
    Med Clin (Barc) 2001 Feb 17;116(6):214-216

  18. Spinal Cord MRI In Suspected Multiple Sclerosis
    Eur Radiol 2000;10(2):368-76

  19. Prognostic value of MR and Magnetization Transfer Imaging findings in patients with Clinically Isolated Syndromes suggestive of Multiple Sclerosis at presentation
    AJNR Am J NeuroRadiol 2000 Jun-Jul;21(6):1034-8

  20. Comparison of MS clinical phenotypes using conventional and Magnetization Transfer MRI
    Neurology 1999 Feb;52(3):588-94

  21. The prognostic value of Brain MRI in Clinically Isolated Syndromes of the CNS
    Brain 1998 Mar;121 ( Pt 3):495-503

  22. Guidelines for the use of Magnetic Resonance techniques in monitoring the treatment of Multiple Sclerosis
    Ann Neurol 1996 Jan;39(1):6-16

  23. The significance of Brain Magnetic Resonance Imaging abnormalities at presentation with Clinically Isolated Syndromes suggestive of Multiple Sclerosis
    Brain 1993 Feb;116 ( Pt 1):135-46

  1. Diagnosis of Multiple Sclerosis: comparison of the Poser Criteria and the new McDonald Criteria
    Acta Neurol Scand 2004 Jun;109(6):385-9

  2. Early development of Multiple Sclerosis is associated with progressive Gray Matter Atrophy in patients presenting with Clinically Isolated Syndrome
    Brain 2004 May;127(Pt 5):1101-7

  3. InfraTentorial lesions predict long-term disability in patients with initial findings suggestive of Multiple Sclerosis
    Arch Neurol 2004 Feb;61(2):217-21

  4. Specificity of Barkhof Criteria in predicting conversion to Multiple Sclerosis when applied to Clinically Isolated BrainStem Syndromes
    Arch Neurol 2004 Feb;61(2):222-4

  5. Long-term follow up of patients with Clinically Isolated Syndromes, Relapsing/Remitting and Secondary/Progressive Multiple Sclerosis
    Mult Scler 2003 Jun;9(3):260-74

  6. New T2 lesions enable an earlier diagnosis of Multiple Sclerosis in Clinically Isolated Syndromes
    Ann Neurol 2003 May;53(5):673-6

  7. AntiMyelin AntiBodies as a predictor of Clinically Definite Multiple Sclerosis after a first DeMyelinating event
    N Engl J Med 2003 Jul 10;349(2):139-45

  8. Baseline MRI characteristics of patients at high risk for Multiple Sclerosis: results from the CHAMPS trial
    Mult Scler 2002 Aug;8(4):330-8

  9. Interferon-beta-1a for early Multiple Sclerosis: CHAMPS trial subgroup analyzes
    Ann Neurol 2002 Apr;51(4):481-90

  10. Normal-Appearing Brain Tissue MTR Histograms in Clinically Isolated Syndromes suggestive of MS
    Neurology 2002 Jul 9;59(1):126-8

  11. Diagnostic criteria of different clinical forms
    Rev Neurol (Paris) 2001 Sep;157(8-9 Pt 2):907-13

  12. Magnetic Resonance Imaging findings predicting subsequent disease course in patients at presentation with Clinically Isolated Syndromes suggestive of Multiple Sclerosis
    Neurol Sci 2001 Nov;22 Suppl 2:S49-51